Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1.

Kendall TJ, Duff CM, Boulter L, Wilson DH, Freyer E, Aitken S, Forbes SJ, Iredale JP, Hastie ND.

Nat Commun. 2019 Oct 15;10(1):4688. doi: 10.1038/s41467-019-12701-9.

2.

Resolving the fibrotic niche of human liver cirrhosis at single-cell level.

Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, Portman JR, Matchett KP, Brice M, Marwick JA, Taylor RS, Efremova M, Vento-Tormo R, Carragher NO, Kendall TJ, Fallowfield JA, Harrison EM, Mole DJ, Wigmore SJ, Newsome PN, Weston CJ, Iredale JP, Tacke F, Pollard JW, Ponting CP, Marioni JC, Teichmann SA, Henderson NC.

Nature. 2019 Nov;575(7783):512-518. doi: 10.1038/s41586-019-1631-3. Epub 2019 Oct 9.

PMID:
31597160
3.

Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.

Jackstadt R, van Hooff SR, Leach JD, Cortes-Lavaud X, Lohuis JO, Ridgway RA, Wouters VM, Roper J, Kendall TJ, Roxburgh CS, Horgan PG, Nixon C, Nourse C, Gunzer M, Clark W, Hedley A, Yilmaz OH, Rashid M, Bailey P, Biankin AV, Campbell AD, Adams DJ, Barry ST, Steele CW, Medema JP, Sansom OJ.

Cancer Cell. 2019 Sep 16;36(3):319-336.e7. doi: 10.1016/j.ccell.2019.08.003.

4.

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation.

Lyall MJ, Thomson JP, Cartier J, Ottaviano R, Kendall TJ, Meehan RR, Drake AJ.

Epigenetics. 2019 Aug 7:1-11. doi: 10.1080/15592294.2019.1649527. [Epub ahead of print]

PMID:
31389294
5.

A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation.

Minutti CM, Modak RV, Macdonald F, Li F, Smyth DJ, Dorward DA, Blair N, Husovsky C, Muir A, Giampazolias E, Dobie R, Maizels RM, Kendall TJ, Griggs DW, Kopf M, Henderson NC, Zaiss DM.

Immunity. 2019 Mar 19;50(3):645-654.e6. doi: 10.1016/j.immuni.2019.01.008. Epub 2019 Feb 12.

6.

Systematic review of management of incidental gallbladder cancer after cholecystectomy.

Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ.

Br J Surg. 2019 Jan;106(1):32-45. doi: 10.1002/bjs.11035.

PMID:
30582640
7.

WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.

McGregor RJ, Chau YY, Kendall TJ, Artibani M, Hastie N, Hadoke PWF.

Br J Cancer. 2018 Dec;119(12):1508-1517. doi: 10.1038/s41416-018-0317-1. Epub 2018 Oct 30.

8.

The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.

Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, van Dijk APJ, Drenth JPH, Tjwa ETTL; Nijmegen Fontan Initiative .

Eur Heart J. 2019 Apr 1;40(13):1057-1068. doi: 10.1093/eurheartj/ehy620.

PMID:
30346512
9.

Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies.

Mole DJ, Fallowfield JA, Kendall TJ, Welsh F, Semple SI, Bachtiar V, Kelly M, Wigmore SJ, James Garden O, Wilman HR, Banerjee R, Rees M, Brady M.

BMC Cancer. 2018 Sep 12;18(1):890. doi: 10.1186/s12885-018-4737-3.

10.

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study.

Hoy AM, McDonald N, Lennen RJ, Milanesi M, Herlihy AH, Kendall TJ, Mungall W, Gyngell M, Banerjee R, Janiczek RL, Murphy PS, Jansen MA, Fallowfield JA.

Biol Open. 2018 Jul 2;7(7). pii: bio033910. doi: 10.1242/bio.033910.

11.

Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.

McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, Kin S, Phillips M, Herlihy AH, Kendall TJ, Brown RM, Neil DAH, Hübscher SG, Hirschfield GM, Fallowfield JA.

Sci Rep. 2018 Jun 15;8(1):9189. doi: 10.1038/s41598-018-27560-5.

12.

Intraductal papillary neoplasm of the bile duct: the role of single-operator cholangioscopy.

Kung JWC, Parks RW, Ireland HM, Kendall TJ, Church NI.

VideoGIE. 2017 Dec 13;3(2):55-57. doi: 10.1016/j.vgie.2017.10.006. eCollection 2018 Feb. No abstract available.

13.

The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss.

Müller MF, Kendall TJ, Adams DJ, Zhou Y, Arends MJ.

Exp Mol Pathol. 2018 Aug;105(1):63-70. doi: 10.1016/j.yexmp.2018.05.008. Epub 2018 Jun 1.

PMID:
29859945
14.

Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.

Munsterman ID, Kendall TJ, Khelil N, Popa M, Lomme R, Drenth JPH, Tjwa ETTL.

Histopathology. 2018 Oct;73(4):612-621. doi: 10.1111/his.13665. Epub 2018 Jul 13.

PMID:
29856896
15.

Paracrine cellular senescence exacerbates biliary injury and impairs regeneration.

Ferreira-Gonzalez S, Lu WY, Raven A, Dwyer B, Man TY, O'Duibhir E, Lewis PJS, Campana L, Kendall TJ, Bird TG, Tarrats N, Acosta JC, Boulter L, Forbes SJ.

Nat Commun. 2018 Mar 9;9(1):1020. doi: 10.1038/s41467-018-03299-5.

16.

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease.

Kendall TJ, Dolman GE, Duff CM, Paish EC, Zaitoun A, Irving W, Fallowfield JA, Guha IN.

Histopathology. 2018 Jul;73(1):90-100. doi: 10.1111/his.13499. Epub 2018 Apr 16.

17.

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.

Eddowes PJ, McDonald N, Davies N, Semple SIK, Kendall TJ, Hodson J, Newsome PN, Flintham RB, Wesolowski R, Blake L, Duarte RV, Kelly CJ, Herlihy AH, Kelly MD, Olliff SP, Hübscher SG, Fallowfield JA, Hirschfield GM.

Aliment Pharmacol Ther. 2018 Mar;47(5):631-644. doi: 10.1111/apt.14469. Epub 2017 Dec 22.

18.

The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.

Campana L, Starkey Lewis PJ, Pellicoro A, Aucott RL, Man J, O'Duibhir E, Mok SE, Ferreira-Gonzalez S, Livingstone E, Greenhalgh SN, Hull KL, Kendall TJ, Vernimmen D, Henderson NC, Boulter L, Gregory CD, Feng Y, Anderton SM, Forbes SJ, Iredale JP.

J Immunol. 2018 Feb 1;200(3):1169-1187. doi: 10.4049/jimmunol.1701247. Epub 2017 Dec 20.

19.

11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis.

Zou X, Ramachandran P, Kendall TJ, Pellicoro A, Dora E, Aucott RL, Manwani K, Man TY, Chapman KE, Henderson NC, Forbes SJ, Webster SP, Iredale JP, Walker BR, Michailidou Z.

Hepatology. 2018 Jun;67(6):2167-2181. doi: 10.1002/hep.29734. Epub 2018 Feb 22.

20.

αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis.

Murray IR, Gonzalez ZN, Baily J, Dobie R, Wallace RJ, Mackinnon AC, Smith JR, Greenhalgh SN, Thompson AI, Conroy KP, Griggs DW, Ruminski PG, Gray GA, Singh M, Campbell MA, Kendall TJ, Dai J, Li Y, Iredale JP, Simpson H, Huard J, Péault B, Henderson NC.

Nat Commun. 2017 Oct 24;8(1):1118. doi: 10.1038/s41467-017-01097-z.

21.

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.

Snowdon VK, Lachlan NJ, Hoy AM, Hadoke PW, Semple SI, Patel D, Mungall W, Kendall TJ, Thomson A, Lennen RJ, Jansen MA, Moran CM, Pellicoro A, Ramachandran P, Shaw I, Aucott RL, Severin T, Saini R, Pak J, Yates D, Dongre N, Duffield JS, Webb DJ, Iredale JP, Hayes PC, Fallowfield JA.

PLoS Med. 2017 Feb 28;14(2):e1002248. doi: 10.1371/journal.pmed.1002248. eCollection 2017 Feb.

22.

Notch3 drives development and progression of cholangiocarcinoma.

Guest RV, Boulter L, Dwyer BJ, Kendall TJ, Man TY, Minnis-Lyons SE, Lu WY, Robson AJ, Gonzalez SF, Raven A, Wojtacha D, Morton JP, Komuta M, Roskams T, Wigmore SJ, Sansom OJ, Forbes SJ.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12250-12255. Epub 2016 Oct 10.

23.

The Angiocrine Factor Rspondin3 Is a Key Determinant of Liver Zonation.

Rocha AS, Vidal V, Mertz M, Kendall TJ, Charlet A, Okamoto H, Schedl A.

Cell Rep. 2015 Dec 1;13(9):1757-64. doi: 10.1016/j.celrep.2015.10.049. Epub 2015 Nov 19.

24.

WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.

Boulter L, Guest RV, Kendall TJ, Wilson DH, Wojtacha D, Robson AJ, Ridgway RA, Samuel K, Van Rooijen N, Barry ST, Wigmore SJ, Sansom OJ, Forbes SJ.

J Clin Invest. 2015 Mar 2;125(3):1269-85. doi: 10.1172/JCI76452. Epub 2015 Feb 17.

25.

Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.

Guest RV, Boulter L, Kendall TJ, Minnis-Lyons SE, Walker R, Wigmore SJ, Sansom OJ, Forbes SJ.

Cancer Res. 2014 Feb 15;74(4):1005-10. doi: 10.1158/0008-5472.CAN-13-1911. Epub 2013 Dec 5.

26.

Asbestosis: demonstration of distinctive interstitial fibroelastosis: a pilot study.

Wick MR, Kendall TJ, Ritter JH.

Ann Diagn Pathol. 2009 Oct;13(5):297-302. doi: 10.1016/j.anndiagpath.2009.05.003. Epub 2009 Aug 6.

PMID:
19751905
27.

p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis.

Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, Iredale JP.

Hepatology. 2009 Mar;49(3):901-10. doi: 10.1002/hep.22701.

PMID:
19072833
28.

The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation.

Conti JA, Kendall TJ, Bateman A, Armstrong TA, Papa-Adams A, Xu Q, Packham G, Primrose JN, Benyon RC, Iredale JP.

Clin Cancer Res. 2008 Oct 15;14(20):6405-13. doi: 10.1158/1078-0432.CCR-08-0816.

29.

DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire.

Rice J, Dossett ML, Ohlén C, Buchan SL, Kendall TJ, Dunn SN, Stevenson FK, Greenberg PD.

Eur J Immunol. 2008 Aug;38(8):2118-30. doi: 10.1002/eji.200838213.

30.

Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study.

Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP, Cope R, Sheron N, Millward-Sadler H, Veldtman GR, Iredale JP.

J Clin Pathol. 2008 Apr;61(4):504-8. Epub 2007 Oct 26.

PMID:
17965217
31.

Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis.

Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP.

J Immunol. 2007 Apr 15;178(8):5288-95.

32.

Reversal of fibrosis: no longer a pipe dream?

Fallowfield JA, Kendall TJ, Iredale JP.

Clin Liver Dis. 2006 Aug;10(3):481-97, viii. Review.

PMID:
17162224
33.

Case series: adult testicular dermoid tumours--mature teratoma or pre-pubertal teratoma?

Kendall TJ, Featherstone JM, Mead GM, Hayes MC, Theaker JM.

Int Urol Nephrol. 2006;38(3-4):643-6.

PMID:
17115296
34.

Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.

Gulizia JM, Kandolf R, Kendall TJ, Thieszen SL, Wilson JE, Radio SJ, Costanzo MR, Winters GL, Miller LL, McManus BM.

Am J Pathol. 1995 Aug;147(2):461-75.

35.

Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy.

McManus BM, Horley KJ, Wilson JE, Malcom GT, Kendall TJ, Miles RR, Winters GL, Costanzo MR, Miller LL, Radio SJ.

Am J Pathol. 1995 Aug;147(2):293-308.

36.

Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts.

Lin H, Wilson JE, Kendall TJ, Radio SJ, Cornhill FJ, Herderick E, Winters GL, Costanzo MR, Porter T, Thieszen SL, et al.

J Heart Lung Transplant. 1994 Sep-Oct;13(5):824-33.

PMID:
7803423
37.

Lipid overload and proteoglycan expression in chronic rejection of the human transplanted heart.

McManus BM, Malcom G, Kendall TJ, Gulizia JM, Wilson JE, Winters G, Costanzo MR, Thieszen S, Radio SJ.

Clin Transplant. 1994 Jun;8(3 Pt 2):336-40.

PMID:
8061377
38.

Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts?

Kendall TJ, Wilson JE, Radio SJ, Kandolf R, Gulizia JM, Winters GL, Costanzo-Nordin MR, Malcom GT, Thieszen SL, Miller LW, et al.

J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S14-20. Review.

PMID:
1320406
39.

Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection.

Radio SJ, McManus BM, Winters GL, Kendall TJ, Wilson JE, Costanzo-Nordin MR, Ye YL.

Mod Pathol. 1991 Sep;4(5):654-60.

PMID:
1836878
40.

Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts.

Winters GL, Kendall TJ, Radio SJ, Wilson JE, Costanzo-Nordin MR, Switzer BL, Remmenga JA, McManus BM.

J Heart Transplant. 1990 Jul-Aug;9(4):364-71.

PMID:
2398430
41.

Normal variability of soluble interleukin-2-receptor levels.

Engel JA, Kendall TJ, Switzer BL, McManus B, Costanzo-Nordin MR.

J Heart Transplant. 1990 May-Jun;9(3 Pt 1):264-5. No abstract available.

PMID:
2355279
42.

Modulation of alveolar macrophage leukotriene B4 released by complement component C5.

Robbins RA, Gossman GL, Allington LA, Kendall TJ, Stull TW, Rennard SI.

J Lab Clin Med. 1990 Apr;115(4):497-503.

PMID:
2157785
43.

Elevation of chemotactic factor inactivator in alcoholic liver disease.

Robbins RA, Zetterman RK, Kendall TJ, Gossman GL, Monsour HP, Rennard SI.

Hepatology. 1987 Sep-Oct;7(5):872-7.

PMID:
3653852
44.

Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.

Robbins RA, Rasmussen JK, Clayton ME, Gossman GL, Kendall TJ, Rennard SI.

J Lab Clin Med. 1987 Sep;110(3):292-9.

PMID:
3611952
45.

Supplemental Content

Loading ...
Support Center